Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | NVRI | WM |
|---|---|---|
| Price | $19.63 | $209.74 |
| Change today | ▼ 0.18% | ▲ 0.38% |
| Market cap | $553.23M | $83.83B |
| Return, 3 months | -14.4% | -9.1% |
| Return, year to date | +9.5% | -3.3% |
| Return, 1 year | +67.3% | -3.1% |
| P/E (TTM) | -1.1 | 29.7 |
| P/B | 0.9 | 8.4 |
| P/E percentile vs own 5y | 91st | 11th |
| Dividend yield | – | 1.69% |
| Revenue growth (YoY, latest qtr) | -40.7% | +4.0% |
| Net profit growth (YoY) | -743.8% | +8.1% |
| Gross margin | -3.4% | 40.6% |
| Operating margin | -24.3% | 18.5% |
| Net margin | -50.3% | 11.1% |
| Return on equity | -90.4% | 29.8% |
| Analyst target vs. price | +52.9% | +25.0% |
| Analyst buy share | 50% | 65% |
| RSI (14) | 40 | 45 |
| 30-day volatility | 39.7% | 15.1% |
| Max drawdown, 1 year | -19.7% | -17.0% |
| Trend read | Leaning bearish | Leaning bearish |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
